Skip to content

Wen Zhang

5 papers in the library · 3 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Esketamine for Postoperative Anxiety After Major Abdominal Tumor Surgery: A Randomized Clinical Trial

Drug Design, Development and Therapy September 1, 2026 Xiaoying Cui, Wutao Chen, Jinyu Wang et al.

Purpose: Postoperative anxiety is common in surgical patients and may impair recovery, especially in the patients with preoperative anxiety. However, effective strategies for treating postoperative anxiety remain limited. We hypothesized that esketamine could reduce postoperative anxiety in patients with preoperative anxiety undergoing major abdominal tumor surgery. Patients and Methods: 180...

Nitrous Oxide as a Recreational Drug of Abuse: Multi-Omics Insights into MAPK/ERK/CREB-Mediated Neurotoxicity and Energy Metabolism Collapse

Molecules August 1, 2026 J. Jia, Wen Zhang, Sitong Nan et al.

Nitrous oxide (N2O), commonly known as laughing gas, is widely used for its anesthetic and analgesic properties in medical settings. However, its recreational abuse has escalated, leading to severe neurological complications including cognitive impairment, yet the underlying mechanisms remain poorly understood. In this study, male C57BL/6 J mice were exposed to either normal air inhalation or...

Chronic Nitrous Oxide Exposure Disrupts Metabolism in Mice: A Plasma Untargeted Metabolomics Study

Metabolites May 1, 2026 J. Jia, Feng-Lin Zhang, Wen Zhang et al.

Background: Nitrous oxide (N2O) is increasingly used as a recreational drug, leading to neurological and systemic toxicities. However, due to the rapid elimination and minimal alteration of nitrogen oxides, the short direct detection window complicates the assessment of N2O exposure. Method: In this study, we investigated the effects of chronic N2O exposure on plasma metabolites using an...

Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex

Neurotherapeutics 2026 Ziran Huang, Xiaoyan Wei, Yihui Wang et al.

Recent clinical breakthroughs hold great promise for the application of psilocybin in the treatments of psychological disorders, such as depression, addiction, and obsessive-compulsive disorder. Psilocybin is a psychedelic whose metabolite, psilocin, is a 5-HT2A receptor agonist. Nevertheless, the underlying mechanisms for the effects of psilocybin on the brain are not fully illustrated, and...

DOI: 10.1016/j.neurot.2026.e00841 (opens in new tab) Psilocybin Inhibitory postsynaptic potential Excitatory postsynaptic potential Hallucinogen +5

Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq

bioRxiv (Cold Spring Harbor Laboratory) January 7, 2024 Ziran Huang, Xiaoyan Wei, Xiaobin Wang et al. 3 citations preprint

Abstract Recent clinical breakthroughs hold great promise for the application of psilocybin in the treatments of psychological disorders, such as depression, addiction, and obsessive-compulsive disorder. Psilocybin is a psychedelic whose metabolite, psilocin, is a 5-HT 2A receptor agonist. Nevertheless, the underlying mechanisms for the effects of psilocybin on the brain are not fully...